optic neuritis: Optic neuritis is inflammation of the optic nerve, the nerve that carries the visual signal from the eye to the brain.The conditionmay cause sudden, reduced vision in the affected eye(s). While the cause of optic neuritis is unknown, it has been associated with autoimmune diseases, infections, multiple sclerosis , drug toxicity and deficiency of vitamin B-12. Vision often returns to normal within 2-3 weeks without treatment. In some cases, corticosteroids are given to speed recovery. If known, the underlying cause should be treated.
Retrobulbar neuritis in diseases classified elsewhere
DOID EFO Endpoint Browser PheWeb
H7_RETROBULBNEURINOTH
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
133 |
4. Check minimum number of eventsNone |
133 |
5. Include endpointsNone |
133 |
6. Filter based on genotype QC (FinnGen only) |
133 |
Control definitions (FinnGen only)
- Control exclude
- H7_OPTNERVE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Retrobulbar neuritis in diseases classified elsewhere
based on the number of shared cases.
Similar with more cases:
- Disorders of optic nerve and visual pathways
- Diseases of the eye and adnexa
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 604 | 436 | 164 |
| Only index persons | 579 | 422 | 157 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.00 |
| Only index persons | 0.01 | 0.02 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 41.59 | 42.05 | 40.49 |
| Only index persons | 41.30 | 41.71 | 40.20 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 133 | 106 | 27 |
| Unadjusted period prevalence (%) | 0.03 | 0.04 | 0.01 |
| Median age at first event (years) | 39.89 | 39.34 | 42.05 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 117
- Matched controls
- 1170
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G35
ICD-10 Finland
Multiple sclerosis
1514.6
126.9
102
5
109
Kela drug reimbursment
Multiple sclerosis
2145.3
115.3
93
*
H48.1*G35
ICD-10 Finland
Retrobulbar neuritis in multiple sclerosis
+∞
110.7
88
*
303
Kela drug reimbursment
Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)
1376.5
99.3
83
*
157
Kela drug reimbursment
Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)
1014.4
87.4
75
*
H46
ICD-10 Finland
Optic neuritis
+∞
83.7
70
*
L03AB07
ATC
interferon beta-1a; parenteral
845.4
55.3
50
*
L03AX13
ATC
glatiramer acetate; parenteral
299.8
41.8
40
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
31.5
41.7
57
34
N86
ICPC
Multiple sclerosis
541.7
39.5
37
*
164
Kela drug reimbursment
Fingolimod
519.8
38.4
36
*
353
Kela drug reimbursment
Cladribine and fingolimod
457.4
34.9
33
*
XCK00
NOMESCO Finland
Perimetry
30.9
33.5
45
23
L04AA27
ATC
fingolimod; oral
381.2
30.3
29
*
TAB00
NOMESCO Finland
Lumbar puncture
25.7
28.3
40
23
L03AB08
ATC
interferon beta-1b; parenteral
347.0
28.0
27
*
L04AX07
ATC
dimethyl fumarate; oral
330.6
26.9
26
*
H48.1
ICD-10 Finland
Retrobulbar neuritis in diseases classified elsewhere
+∞
26.0
24
*
2AB04
NOMESCO Finland
NA
314.4
25.8
25
*
N04BB01
ATC
amantadine; oral
72.7
25.3
28
5
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
44.1
24.8
30
9
G37.9
ICD-10 Finland
Demyelinating disease of central nervous system, unspecified
99.5
22.6
24
*
L04AA31
ATC
teriflunomide; oral
+∞
21.5
20
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
9.3
21.0
49
84
XCD10
NOMESCO Finland
Electrophysiological examination of eye
56.6
20.0
23
5
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
47.1
19.4
23
6
XKD06
NOMESCO Finland
Physiologic investigation of micturition
53.6
19.0
22
5
ZX120
NOMESCO Finland
Intravenous
9.9
18.6
40
58
F02.89*G35
ICD-10 Finland
Dementia in multiple sclerosis
+∞
18.2
17
*
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
11.3
17.0
33
39
N07XX09
ATC
[U] dimethyl fumarate; oral
+∞
16.0
15
*
M03BX01
ATC
baclofen; systemic
24.2
15.8
22
11
XKD00
NOMESCO Finland
Uroflowmetry
9.5
14.1
30
41
XA800
NOMESCO Finland
Neuropsychological investigation
14.1
14.1
24
21
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
16.8
13.4
21
15
4AA23
NOMESCO Finland
NA
+∞
12.7
12
*
H48.1*A69.2
ICD-10 Finland
Retrobulbar neuritis in Lyme disease
+∞
12.7
12
*
H02AB04
ATC
methylprednisolone; systemic
5.8
12.7
40
96
XCW99
NOMESCO Finland
Other investigative procedure of eye
7.3
12.3
31
55
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
9.3
11.9
25
33
N03AE01
ATC
clonazepam; systemic
10.6
11.4
22
25
G04BD04
ATC
oxybutynin; oral, transdermal
13.1
10.5
18
16
Z3231
NOMESCO Finland
Registered nurse
4.0
10.3
52
196
G04BD12
ATC
mirabegron; oral
8.5
10.1
22
31
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
28.9
10.1
13
5
R35
ICD-10 Finland
Polyuria
12.2
9.7
17
16
G04BD09
ATC
trospium; oral
24.1
9.6
13
6
G36.0
ICD-10 Finland
Neuromyelitis optica [Devic]
+∞
9.5
9
*
Z3226
NOMESCO Finland
Physiotherapist
4.3
9.3
38
117
H53.9
ICD-10 Finland
Visual disturbance, unspecified
13.0
8.9
15
13
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
22.0
8.7
12
6
R4110
NOMESCO Finland
Physiotherapy
3.7
8.6
45
170
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
96.7
8.5
9
*
N06BA07
ATC
modafinil; oral
+∞
8.4
8
*
R4150
NOMESCO Finland
Neuropsychological rehabilitation
+∞
8.4
8
*
H47.2
ICD-10 Finland
Optic atrophy
+∞
8.4
8
*
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
8.3
8.3
18
25
UKC02
NOMESCO Finland
Cystoscopy
5.6
7.9
23
49
N28
ICPC
Limited function/disability (N)
48.3
7.8
9
*
ZXD10
NOMESCO Finland
Scheduled procedure
3.1
7.7
61
304
Z3229
NOMESCO Finland
Other healthcare associate professional
5.9
7.6
21
42
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
85.3
7.5
8
*
R1250
NOMESCO Finland
Evaluation of functional capability
17.1
7.4
11
7
L04AA40
ATC
cladribine; oral
+∞
7.4
7
*
L04AX01
ATC
azathioprine; systemic
6.7
7.3
18
31
H53.1
ICD-10 Finland
Subjective visual disturbances
6.7
6.9
17
29
XF400
NOMESCO Finland
ECG with 12 standard connections
4.3
6.9
26
73
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
5.0
6.9
22
52
N05CF01
ATC
zopiclone; oral
3.1
6.9
46
204
J01EA01
ATC
trimethoprim; systemic
3.2
6.9
43
182
N99
ICPC
Neurological disease other
42.6
6.8
8
*
N29
ICPC
Neurological sympt/complt other
24.1
6.8
9
*
A02BC02
ATC
pantoprazole; systemic
2.9
6.7
85
556
ZXA10
NOMESCO Finland
Bilateral
3.7
6.7
31
105
TKC20
NOMESCO Finland
Catheterisation of bladder
6.7
6.6
16
27
G04BD07
ATC
tolterodine; oral
12.0
6.4
11
10
Z2445
NOMESCO Finland
Psychologist
6.4
6.4
16
28
N39.4
ICD-10 Finland
Other specified urinary incontinence
5.6
6.4
18
37
ZXE00
NOMESCO Finland
One hour or less
2.7
6.3
61
333
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
28.4
6.3
8
*
TPH04
NOMESCO Finland
Cathetrisation of vein
3.4
6.3
33
121
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
13.5
6.2
10
8
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
4.5
6.1
21
54
L28
ICPC
Limited function/disability (L)
4.7
6.1
20
49
G04BD08
ATC
solifenacin; oral
7.1
6.1
14
22
N03AX12
ATC
gabapentin; oral
3.5
6.0
29
101
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3014148) Varicella zoster virus Ab [Titer] in Serum
34
18
25.03
44.62
1.2
1.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
34
18
25.03
44.62
1.2
1.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
65
142
8.00
32.03
7.3
2.2
e6/l
1.1
0.9
0.28
45
77
(42870588) Differential panel, method unspecified - Blood
101
354
8.70
30.48
15.3
5.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
59
129
7.42
28.65
7.9
2.4
e6/l
5.1
3.9
0.25
38
64
(3001604) Monocytes [#/volume] in Blood
121
550
14.30
26.75
19.0
5.7
e9/l
0.5
0.5
0.70
113
494
(3006315) Basophils [#/volume] in Blood
120
554
12.93
25.64
19.1
5.7
e9/l
0.0
0.0
2.91
112
496
(3030467) Casts [#/volume] in Urine by Automated count
79
249
6.35
25.60
10.5
2.4
e6/l
0.2
0.3
0.63
68
178
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
89
315
6.52
25.21
10.3
2.8
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
121
577
13.16
24.55
19.0
5.6
e9/l
1.5
2.0
5.00
114
525
(3013115) Eosinophils [#/volume] in Blood
120
573
12.19
24.11
19.6
6.1
e9/l
0.2
0.2
0.76
112
522
(3019069) Monocytes/100 leukocytes in Blood
114
519
9.38
24.02
18.5
6.0
%
9.0
8.0
3.30
114
491
(36304419) Bacteria [Presence] in Urine
79
261
5.99
23.91
10.5
2.4
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
113
517
8.88
23.45
18.5
5.8
%
2.9
2.7
0.55
113
484
(3022096) Basophils/100 leukocytes in Blood
111
504
8.27
23.07
18.9
5.7
%
0.7
0.7
0.21
111
470
(3002582) Erythrocytes [#/volume] in Urine
80
278
5.71
22.52
10.7
2.8
e6/l
10.9
255.5
0.53
69
210
(3044290) Cell count panel - Cerebral spinal fluid
24
23
12.51
22.45
1.0
1.7
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
114
539
8.81
22.40
18.5
5.8
%
24.7
29.6
5.48
114
510
(3023410) Appearance of Cerebral spinal fluid
20
15
15.52
21.57
1.0
1.6
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
89
354
5.58
20.87
12.4
3.3
e6/l
17.5
114.6
0.61
71
227
(3011397) Hemoglobin [Presence] in Urine by Test strip
71
236
5.31
20.73
6.1
3.1
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
19
0
+∞
20.32
1.4
0.0
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
18
13
15.86
19.74
1.0
1.2
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
120
646
9.77
18.96
21.4
9.5
e9/l
3.5
4.0
2.37
112
577
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
18
14
14.71
18.93
1.0
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
27
40
8.21
18.17
1.6
1.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
17
13
14.85
18.01
1.0
1.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
99
478
5.19
16.98
20.7
8.4
e9/l
0.0
0.0
0.68
86
394
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
23
32
8.48
16.23
1.0
1.3
e6/l
8.0
2.4
1.53
15
25
(3016018) Differential panel - Cerebral spinal fluid
15
11
15.24
16.18
1.0
1.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
20
24
9.63
15.81
1.4
1.3
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
19
6
36.54
15.28
1.0
1.0
—
—
—
0
0
(40758558) Short blood count panel - Blood
70
278
4.20
15.22
16.6
7.1
—
—
—
0
0
(3015736) pH of Urine
89
420
4.38
15.13
5.8
2.9
—
—
—
0
0
(4027681)
18
5
41.21
14.87
1.0
1.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
67
288
3.67
12.42
7.9
2.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
37
107
4.41
12.05
1.7
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
49
179
3.75
11.48
1.6
1.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
92
516
3.54
10.64
9.9
4.6
estimate
0.0
0.0
—
9
105
(3035350) Ketones [Presence] in Urine by Test strip
92
524
3.45
10.21
6.8
3.2
estimate
0.0
0.0
—
9
104
(3023511) Choriogonadotropin [Units/volume] in Urine
23
53
5.04
9.78
1.5
1.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
91
524
3.33
9.73
6.7
3.3
estimate
0.0
0.0
—
9
99
(3037467) Urinalysis macro (dipstick) panel - Urine
111
768
3.69
7.87
11.1
3.9
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
26
86
3.51
6.79
1.5
1.8
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
10
7
15.30
6.51
1.1
1.0
miu/ml
1753.4
1850.4
—
10
7
(3052851) Hemolysis interference index of Serum or Plasma
12
22
5.90
6.41
2.9
3.1
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
10
15
7.13
6.40
1.3
1.0
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
133
1191
+∞
5.87
22.2
9.0
u/l
26.4
25.3
0.37
133
1158
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
25
89
3.23
5.79
1.5
1.8
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
15
38
4.32
5.61
1.3
1.8
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
43
210
2.55
5.56
6.5
3.9
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
122
978
3.99
5.22
31.5
13.4
%
13.5
13.6
0.20
122
969
(3018418) pH of Serum or Plasma
48
256
2.37
5.07
6.0
3.9
ph
7.4
7.4
—
6
47
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
22
80
3.10
4.90
2.6
1.8
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
24
93
2.93
4.79
3.5
2.2
u/l
28.9
28.2
0.05
19
78
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
10
21
5.07
4.61
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
10
21
5.07
4.61
1.3
1.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
51
296
2.17
4.30
1.8
1.7
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
14
42
3.61
4.17
5.0
1.9
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
7
7
10.46
4.06
1.6
1.6
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
7
7
10.46
4.06
1.0
1.6
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
12
34
3.78
3.86
4.1
1.5
%
101.9
99.5
0.13
12
34
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
29
139
2.39
3.79
1.7
1.9
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
57
360
2.02
3.74
1.8
2.0
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
11
31
3.78
3.56
4.4
1.9
%
141.2
161.3
0.44
11
31
(3000991) Gas panel - Venous blood
15
53
3.06
3.49
25.5
4.5
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
64
437
1.90
3.24
11.3
6.0
mmol/l
1.2
1.2
0.52
56
366
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
59
395
1.89
3.15
11.7
5.3
mmol/l
1.2
1.2
0.52
59
361
(3014007) Fractional oxyhemoglobin in Arterial blood
11
34
3.44
3.13
7.5
8.4
%
95.3
95.5
0.09
11
34
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
5
5
10.32
3.00
6.2
1.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
55
365
1.86
2.98
2.0
1.8
pmol/l
90.9
94.9
0.35
30
199
(40761535) Cells panel - Urine sediment
16
65
2.66
2.92
7.4
3.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
6
183
0.30
2.80
1.0
1.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
43
270
1.88
2.74
2.5
1.4
g/l
2.0
2.3
0.67
30
170
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
9
25
3.78
2.63
1.0
1.4
—
—
—
0
0
(3036489) Thrombin time
12
44
2.90
2.62
4.3
1.5
s
22.2
20.5
0.43
12
35
(40760888) Immunoglobulin light chains.free panel - Serum
6
11
5.65
2.57
6.5
2.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
119
1040
2.37
2.49
19.7
9.7
ml/min/173m2
97.5
91.2
3.13
106
854
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
5
155
0.30
2.49
1.4
2.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
28
451
0.52
2.45
2.6
2.3
—
—
—
0
0
(4268621)
6
12
5.18
2.43
2.0
2.3
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
7
17
4.28
2.39
5.4
1.1
g/l
0.1
0.0
—
7
17
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
7
17
4.28
2.39
5.4
1.1
g/l
0.0
0.0
—
7
17
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
7
17
4.28
2.39
5.4
1.1
g/l
0.0
0.0
—
7
17
(3032080) INR in Blood by Coagulation assay
45
299
1.76
2.34
11.3
5.3
inr
1.1
1.1
—
8
96
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
7
18
4.04
2.28
5.4
1.1
g/l
0.6
1.7
—
7
18
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
9
29
3.25
2.27
5.4
7.6
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
7
19
3.83
2.18
5.4
1.1
g/l
8.0
10.7
—
7
19
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
27
156
1.92
2.17
3.2
2.5
ng/l
68.1
202.4
0.50
15
86
(3044889) 12 lead EKG panel
84
676
1.66
2.06
3.3
3.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
6
16
3.87
1.96
1.3
1.0
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
7
22
3.30
1.91
5.4
1.0
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
7
22
3.30
1.91
5.4
1.0
g/l
3.7
3.8
—
7
17
(3019550) Sodium [Moles/volume] in Serum or Plasma
121
1092
2.20
1.87
22.2
10.7
mmol/l
139.5
139.7
0.24
121
1058
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
5
12
4.28
1.84
1.0
1.3
%
91.2
103.1
—
5
12
(40760892) CBC W Ordered Manual Differential panel - Blood
41
286
1.63
1.73
10.7
4.8
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
11
49
2.36
1.68
1.0
1.4
—
—
—
0
0
(4306422)
6
19
3.26
1.68
1.0
1.3
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
8
32
2.59
1.62
1.3
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
5
15
3.42
1.53
4.6
2.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
7
27
2.68
1.53
1.0
1.4
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
7
27
2.68
1.53
1.1
1.6
nmol/l
70.3
33.6
—
7
27
(3019832) Treponema pallidum Ab [Presence] in Serum
14
245
0.52
1.51
1.3
1.7
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
6
22
2.81
1.45
1.2
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
10
46
2.27
1.44
1.2
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
5
117
0.41
1.33
1.6
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
6
24
2.57
1.32
1.0
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
36
259
1.53
1.31
7.2
2.8
mmol/l
7.5
8.0
0.25
31
221
(3003694) ABO and Rh group [Type] in Blood
27
382
0.63
1.30
1.1
1.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
9
44
2.12
1.29
1.4
1.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
5
18
2.84
1.29
4.4
4.9
%
56.8
58.3
—
5
18
(3030905) Polymorphonuclear cells [#/volume] in Blood
5
18
2.84
1.29
4.4
4.6
e9/l
4.1
4.0
—
5
18
(3037522) Nuclear Ab [Titer] in Serum
26
174
1.61
1.28
1.3
1.4
titre
373.3
415.1
—
6
37
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
42
314
1.49
1.28
2.2
2.4
u/l
51.3
56.2
0.79
42
294
(3016502) Oxygen saturation in Arterial blood
12
63
1.99
1.27
6.8
6.5
%
96.8
96.7
0.07
12
58
(3049717) Cytology report of Urine Cyto stain
6
25
2.46
1.26
1.7
1.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
11
196
0.52
1.25
1.3
1.5
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
127
1203
2.23
1.24
12.6
10.1
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
13
72
1.89
1.20
6.5
6.1
kpa
13.4
12.7
0.19
13
67
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
13
72
1.89
1.20
6.5
6.1
kpa
4.9
5.1
0.19
13
67
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
35
256
1.50
1.18
2.6
1.7
mg/l
0.6
0.8
1.00
25
192
(3002032) Base excess in Venous blood by calculation
11
58
1.98
1.16
26.9
3.0
mmol/l
1.6
2.4
0.41
11
42
(3021447) Carbon dioxide [Partial pressure] in Venous blood
11
59
1.94
1.11
26.9
3.0
kpa
6.1
5.7
0.54
11
59
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
102
1101
0.68
0.99
3.6
3.6
mmol/l
4.8
4.8
0.15
96
1035
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
28
0.00
0.99
0.0
1.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
113
1045
1.54
0.98
6.2
4.8
mu/l
1.9
1.7
0.53
107
979
(3012544) pH of Venous blood
11
63
1.81
0.93
27.8
2.8
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
8
42
1.96
0.90
1.0
1.8
g/l
0.3
0.2
—
8
42
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
17
246
0.65
0.89
1.2
1.3
u/ml
1.3
7.2
—
6
98
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
102
1096
0.70
0.89
3.5
3.6
mmol/l
1.5
1.5
0.02
95
1029
(3017181) Myelocytes/100 leukocytes in Blood
13
82
1.65
0.81
7.8
4.3
%
0.7
0.6
—
6
24
(1001926) Buprenorphine [Presence] in Urine by Screen method
11
66
1.73
0.81
1.1
1.5
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
24
0.00
0.80
0.0
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
25
0.00
0.80
0.0
1.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
12
75
1.66
0.78
8.4
4.6
%
0.0
0.0
—
5
21
(3011288) Drugs identified in Urine by Screen method
9
56
1.65
0.74
1.2
1.8
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
7
39
1.84
0.74
1.0
1.6
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
13
85
1.59
0.72
22.9
18.2
—
1.3
—
0
19
(3009542) Hematocrit [Volume Fraction] of Blood
116
1095
1.46
0.72
33.8
11.3
%
39.0
40.5
1.01
102
914
(3012516) Albumin [Mass/volume] in Urine
27
207
1.38
0.71
9.0
3.1
mg/l
94.8
107.9
0.09
20
128
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
37
299
1.33
0.70
1.7
1.5
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
5
27
1.88
0.69
2.0
1.9
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
36
292
1.32
0.67
1.3
1.3
u/ml
0.6
1.5
—
8
86
(3001019) Free T4 and TSH panel - Serum or Plasma
6
101
0.58
0.65
1.0
1.8
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
45
527
0.78
0.65
2.7
3.8
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
8
50
1.64
0.62
36.3
2.4
kpa
5.5
4.8
—
8
50
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
0
20
0.00
0.61
0.0
1.8
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
0
20
0.00
0.61
0.0
1.6
—
6.7
—
0
9
(4094501)
0
22
0.00
0.60
0.0
1.0
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
0
22
0.00
0.60
0.0
5.0
—
29.0
—
0
14
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
23
0.00
0.59
0.0
1.3
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
6
35
1.75
0.58
47.3
2.3
%
0.7
0.6
—
6
35
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
6
36
1.70
0.57
47.3
2.3
%
1.4
1.1
—
6
36
(3029937) Albumin [Presence] in Urine by Test strip
32
262
1.29
0.55
9.6
3.6
estimate
0.0
0.0
—
9
104
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
38
319
1.27
0.54
1.4
1.7
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
6
96
0.61
0.54
1.5
1.3
iu/l
38.0
22.0
—
6
81
(3013139) Helicobacter pylori Ag [Presence] in Stool
11
75
1.51
0.52
1.0
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
20
154
1.35
0.52
2.0
1.9
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
15
111
1.40
0.49
1.7
1.2
iu/ml
93.4
156.4
—
8
45
(4035726)
5
83
0.59
0.47
1.8
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
53
469
1.22
0.47
2.1
2.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
11
77
1.47
0.47
1.1
1.5
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
13
173
0.72
0.45
1.5
1.6
pmol/l
332.0
459.5
2.69
13
153
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
100
1050
0.81
0.43
3.1
3.3
mmol/l
1.2
1.2
0.76
92
977
(3020682) Albumin/Creatinine [Ratio] in Urine
27
224
1.26
0.43
9.7
3.7
mg/mmol
13.0
14.8
0.10
21
134
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
0
16
0.00
0.41
0.0
4.0
—
49.0
—
0
16
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
32
273
1.23
0.40
1.5
1.6
mmol/l
1.4
1.3
0.22
27
243
(3025468) Yersinia sp identified in Specimen by Organism specific culture
0
18
0.00
0.40
0.0
1.8
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
0
18
0.00
0.40
0.0
1.8
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
0
18
0.00
0.40
0.0
1.8
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
18
0.00
0.40
0.0
1.4
—
7.5
—
0
11
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
100
1047
0.82
0.39
3.6
3.7
mmol/l
5.7
5.7
0.17
94
978
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
0
19
0.00
0.39
0.0
1.7
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
0
19
0.00
0.39
0.0
1.7
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
0
19
0.00
0.39
0.0
1.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
101
960
1.22
0.39
4.5
3.9
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
6
42
1.45
0.36
1.3
1.3
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
6
43
1.41
0.35
47.7
3.3
g/l
136.7
134.5
—
6
43
(3027008) Opiates [Presence] in Urine
11
82
1.37
0.35
1.1
1.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
6
44
1.38
0.35
1.2
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
44
1.38
0.35
1.2
1.1
—
—
—
0
0
(3019225) pH of Specimen
6
89
0.66
0.34
4.8
5.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
15
119
1.29
0.33
3.5
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
11
83
1.35
0.33
1.1
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
11
83
1.35
0.33
1.1
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
11
84
1.34
0.31
1.1
1.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
20
237
0.82
0.31
1.6
1.9
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
12
151
0.77
0.30
1.5
1.6
—
—
—
0
0
(3022621) pH of Urine by Test strip
8
62
1.31
0.28
1.8
2.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
8
63
1.29
0.28
1.6
1.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
28
245
1.18
0.27
2.2
1.8
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
8
65
1.25
0.27
1.8
1.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
16
132
1.24
0.27
1.7
2.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
9
75
1.21
0.25
3.9
1.6
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
6
83
0.71
0.25
7.7
3.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
5
40
1.26
0.22
1.6
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
5
40
1.26
0.22
2.2
5.8
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
108
1109
0.86
0.22
4.0
3.9
mmol/l
2.9
2.9
0.05
99
1042
(3000330) Specific gravity of Urine by Test strip
5
42
1.20
0.21
3.0
2.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(44813793)
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
8.8
—
0.7
—
0
10
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
10
80
1.27
0.21
3.3
3.0
%
1.4
1.9
—
10
74
(3002256) Pathology report gross observation
12
144
0.82
0.21
1.4
1.2
—
—
—
0
0
(3000492) Spirometry study
9
112
0.79
0.21
1.4
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
9
113
0.78
0.21
1.1
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
13.9
—
1062.1
—
0
14
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
15.8
—
1901.9
—
0
14
(3003327) Ova and parasites identified in Stool by Light microscopy
6
51
1.18
0.19
1.7
1.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
14
120
1.19
0.17
2.1
1.7
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
8
70
1.15
0.16
2.8
1.6
mu/l
733.3
316.8
—
8
62
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
11
92
1.21
0.16
3.5
4.2
%
16.9
19.9
—
5
39
(3005322) IgE [Units/volume] in Serum or Plasma
6
78
0.76
0.16
1.0
1.3
u/ml
1078.9
446.1
—
6
68
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
9
109
0.81
0.13
1.7
1.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
15
135
1.13
0.10
2.0
1.3
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
6
53
1.14
0.09
6.3
3.2
kpa
6.2
4.9
—
6
48
(3044640) Blood type and Crossmatch panel - Blood
35
333
1.07
0.08
2.5
2.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
42
403
1.06
0.08
9.0
3.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
6
73
0.81
0.08
1.5
1.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
13
118
1.11
0.07
3.5
3.8
ug/l
1.4
1.7
0.51
13
109
(3041096) Erythrocytes [Presence] in Urine by Automated
29
304
0.94
0.06
6.0
2.9
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
12
110
1.10
0.05
2.3
2.0
nmol/l
331.9
371.3
0.26
12
100
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
12
110
1.10
0.05
7.8
4.8
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
13
138
0.94
0.02
1.7
1.2
—
—
—
0
0
(3013512) EKG study
26
252
1.04
0.02
2.8
3.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
26
263
0.99
0.00
1.5
2.0
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
32
315
1.02
0.00
3.2
2.9
ng/l
19.9
20.0
0.01
14
161
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
25
248
1.01
0.00
1.3
1.3
iu/ml
9.6
31.7
—
7
74
(3016244) Insulin [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.9
—
18.9
—
0
9
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
9
0.00
0.00
0.0
1.0
—
158.1
—
0
9
(40768806) Pleura Pathology biopsy report
0
9
0.00
0.00
0.0
2.4
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.0
—
470.5
—
0
6
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
0.3
—
0
5
(3003434) Protein [Mass/volume] in Pleural fluid
0
8
0.00
0.00
0.0
1.6
—
34.4
—
0
8
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806118)
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
7
74
0.94
0.00
1.0
1.4
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
5
0.00
0.00
0.0
3.6
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
90.6
—
0
8
(3000093) Morphology [Interpretation] in Blood Narrative
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
12.7
—
0
6
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
10.7
—
0
5
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
0
8
0.00
0.00
0.0
1.3
—
203.5
—
0
8
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
5
0.00
0.00
0.0
1.0
—
5.5
—
0
5
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
6.6
—
248.2
—
0
5
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(44790048)
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
9
91
0.99
0.00
9.9
3.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4146454)
0
8
0.00
0.00
0.0
3.0
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3008898) HLA-B27 [Presence]
9
94
0.95
0.00
1.0
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3035880) pH of Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.2
—
27.0
—
0
5
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
161.4
—
0
5
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
5.8
—
145.6
—
0
5
(3044242) Glucose [Moles/volume] in Arterial blood
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.6
—
—
—
0
0
(44790049)
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
6
68
0.88
0.00
3.0
2.6
u/ml
34.7
25.7
—
6
62
(3013727) Leukocytes other/100 leukocytes in Blood
0
5
0.00
0.00
0.0
4.0
—
49.1
—
0
5
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
21.1
—
0
6
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
5
56
0.89
0.00
1.0
1.7
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
7.6
—
0
5
(44790047)
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
7
70
1.00
0.00
1.0
1.0
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint H7_RETROBULBNEURINOTH and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have H7_RETROBULBNEURINOTH.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: H7_RETROBULBNEURINOTH – Retrobulbar neuritis in diseases classified elsewhere
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data